Clinical Trial Update: Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 open-label trial of dipyridamole in hospitalized COVID-19 patients (terminated; results posted).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia
• Vascular Complications of COVID-19

Drugs mentioned

• Dipyridamole (Dipyridamole)

Snippet

Sponsor: UConn Health | Conditions: COVID-19 Pneumonia, Vascular Complications | Phase 2 | Status: TERMINATED | Results posted: 2023-04-21